Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Mossman
OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Patient-Reported Outcomes With Nivolumab in Advanced Solid Cancers
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Impact of Nivolumab Versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients With Advanced Squamous Non-Small Cell Lung Cancer: Results From the CheckMate 017 Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Patient-Reported Outcomes From FLAURA: Osimertinib Versus Erlotinib or Gefitinib in Patients With EGFR-mutated Advanced Non-Small-Cell Lung Cancer
European Journal of Cancer
Cancer Research
Oncology
Nivolumab in Metastatic Non–Small Cell Lung Cancer
Journal of the Advanced Practitioner in Oncology
OA 17.05 IFCT-1502 CLINIVO: Real-Life Experience With Nivolumab in 600 Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Acute Interstitial Nephritis in a Patient With Non-Small Cell Lung Cancer Under Immunotherapy With Nivolumab
Case Reports in Nephrology
